CITIGROUP INC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$29,736,320
+19.1%
30,656,000
+20.6%
0.02%
+37.5%
Q2 2023$24,963,410
-9.1%
25,414,000
-5.0%
0.02%
-15.8%
Q1 2023$27,451,121
+2455.9%
26,756,000
+2543.9%
0.02%
+1800.0%
Q4 2022$1,074,036
+260.4%
1,012,000
+239.6%
0.00%
Q1 2022$298,000
-79.5%
298,000
-78.6%
0.00%
-100.0%
Q4 2021$1,453,000
+195.9%
1,390,000
+193.2%
0.00%
Q2 2021$491,000
-8.1%
474,000
-10.2%
0.00%
Q1 2021$534,000
-65.3%
528,000
-63.2%
0.00%
-100.0%
Q4 2020$1,541,000
-11.7%
1,436,000
-13.7%
0.00%0.0%
Q3 2020$1,745,000
+10164.7%
1,663,000
+11778.6%
0.00%
Q2 2020$17,000
+13.3%
14,0000.0%0.00%
Q1 2020$15,0000.0%14,0000.0%0.00%
Q4 2019$15,000
+36.4%
14,000
+27.3%
0.00%
Q3 2019$11,000
-94.2%
11,000
-94.1%
0.00%
Q1 2019$191,000
-72.6%
187,000
-73.3%
0.00%
-100.0%
Q4 2017$697,000
-65.6%
700,000
-65.0%
0.00%
-50.0%
Q3 2017$2,026,0002,000,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2019
NameSharesValueWeighting ↓
Wellesley Asset Management 53,670$57,726,0003.34%
SHENKMAN CAPITAL MANAGEMENT INC 26,959,000$29,149,0003.04%
ADVENT CAPITAL MANAGEMENT /DE/ 84,134,000$90,539,0001.93%
Cheyne Capital Management (UK) LLP 3,220,000$3,452,0001.75%
PFM Health Sciences, LP 40,300,000$43,210,0001.52%
Sonora Investment Management, LLC 6,370,000$6,807,0000.56%
MACKAY SHIELDS LLC 66,018,000$70,980,0000.49%
ZAZOVE ASSOCIATES LLC 1,500,000$1,608,0000.20%
IRON Financial LLC 275,000$295,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$3,216,0000.08%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders